S836 Health-Related Quality of Life of Week 8 Responders and Non-Responders: Results from the RBX2660 Phase 3 Randomized, Placebo-Controlled Trial in Recurrent Clostridioides difficile Infection (PUNCH CD3)

Authors :: Paul Feuerstadt
Erik R. Dubberke
Amy Guo
Adam Harvey
Min Yang
Viviana Garcia-Horton
Mirko Fillbrunn
Jonathan Salcedo
Glenn Tillotson
Lindy Bancke
Kevin W. Garey
Source :: American Journal of Gastroenterology. 117:e604-e605
Publication Year :: 2022
Publisher :: Ovid Technologies (Wolters Kluwer Health), 2022.

Tools